Evidence map›Paper›PMID 17913902›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2007

Brain-derived neurotrophic factor rescues synaptic plasticity in a mouse model of fragile X syndrome.

Julie C Lauterborn, Christopher S Rex, Eniko Kramár, Lulu Y Chen, Vijay Pandyarajan, Gary Lynch, Christine M Gall

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 156 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
156citing papers in PubMed, 1 pooled it
9.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

156 citing papers in PubMed, 1 synthesis or guideline pooled it, 238 citations in OpenAlex.

  1. Age matters.The European journal of neuroscience · 2009
    Pooled it
  2. Trial
  3. Trial
  4. Lasting effects of early-life oxytocin treatment on LTP and episodic memory in a mouse model of Fragile X syndrome.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  5. Article
  6. Article
  7. bioRxiv : the preprint server for biology · 2026
    Article
  8. Review
  9. Review
  10. Hippocampal Place Cell Sequences Are Impaired in a Rat Model of Fragile X Syndrome.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Cage effects on synaptic plasticity and its modulation in a mouse model of fragile X syndrome.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Article
  15. Article
  16. Article
  17. Mouse models of fragile X-related disorders.Disease models & mechanisms · 2023
    Review
  18. Article
  19. Review
  20. Article

96 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Julie C LauterbornDepartment of Anatomy and Neurobiology, University of California, Irvine, California 92697-4292, USA. jclauter@uci.edu
Christopher S Rex
Eniko Kramár
Lulu Y Chen
Vijay Pandyarajan
Gary Lynch
Christine M Gall
University of California, Irvine · USInstitute of Neurobiology · BG

Funding

The Spine Cytoskeleton and Memory DisordersP01NS045260 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI GALL, CHRISTINE M · 2003 to 2015
$14.4M
INTEGRIN REGULATION AND FUNCTIONS IN ADULT BRAINR01NS037799 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI GALL, CHRISTINE M · 1998 to 2007
$1.6M
Integrins and LTP consolidationR01NS051823 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI LYNCH, GARY S · 2005 to 2008
$1.0M
Hypothalamic-pituitary-adrenal function Fragile X mouseR03HD051829 · NICHD · UNIVERSITY OF CALIFORNIA-IRVINE · PI LAUTERBORN, JULIE C · 2006 to 2007
$150k
INFLUENCE OF AGE AND RACE ON BONE HEALTHK08AG000358 · NIA · MOUNT SINAI SCHOOL OF MEDICINE OF CUNY · PI MEIER, DIANE E · 1987 to 1991
–
NIA NIH HHS AG00358NICHD NIH HHS HD51829NICHD NIH HHS R03 HD051829NINDS NIH HHS NS045260NINDS NIH HHS NS051823NINDS NIH HHS NS37799NINDS NIH HHS P01 NS045260NINDS NIH HHS R01 NS037799NINDS NIH HHS R01 NS051823
6 · The paper itself

Abstract

Mice lacking expression of the fragile X mental retardation 1 (Fmr1) gene have deficits in types of learning that are dependent on the hippocampus. Here, we report that long-term potentiation (LTP) elicited by threshold levels of theta burst afferent stimulation (TBS) is severely impaired in hippocampal field CA1 of young adult Fmr1 knock-out mice. The deficit was not associated with changes in postsynaptic responses to TBS, NMDA receptor activation, or levels of punctate glutamic acid decarboxylase-65/67 immunoreactivity. TBS-induced actin polymerization within dendritic spines was also normal. The LTP impairment was evident within 5 min of induction and, thus, may not be secondary to defects in activity-initiated protein synthesis. Protein levels for both brain-derived neurotrophic factor (BDNF), a neurotrophin that activates pathways involved in spine cytoskeletal reorganization, and its TrkB receptor were comparable between genotypes. BDNF infusion had no effect on baseline transmission or on postsynaptic responses to theta burst stimulation, but nonetheless fully restored LTP in slices from fragile X mice. These results indicate that the fragile X mutation produces a highly selective impairment to LTP, possibly at a step downstream of actin filament assembly, and suggest a means for overcoming this deficit. The possibility of a pharmacological therapy based on these results is discussed.

Indexed as

ActinsAnalysis of VarianceAnimalsBrain-Derived Neurotrophic FactorCofilin 1Dendritic SpinesDisease Models, AnimalElectric StimulationExcitatory Postsynaptic PotentialsFragile X Messenger Ribonucleoprotein 1Fragile X SyndromeGene Expression RegulationHippocampusIn Vitro TechniquesLong-Term PotentiationMiceActinsBrain-Derived Neurotrophic FactorCofilin 1Fmr1 protein, mouseFragile X Messenger Ribonucleoprotein 1Receptors, N-Methyl-D-Aspartate

Identifiers

PMID17913902
PMCPMC6672822
OpenAlexW2032702335

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.